Therapeutic Drug Monitoring in Arterial Hypertension
(1) Background: This study was planned to assess the concentration of antihypertensive drugs (AHD) in the blood serum in patients with controlled and uncontrolled arterial hypertension (AH). (2) Methods: We assessed 46 patients with AH. Based on the results of 24 h blood pressure monitoring (ABPM),...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-05-01
|
| Series: | Journal of Personalized Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4426/13/5/815 |
| _version_ | 1797599462616465408 |
|---|---|
| author | Sergey Seleznev Alexey Shchulkin Pavel Mylnikov Elena Yakusheva Natalia Nikulina |
| author_facet | Sergey Seleznev Alexey Shchulkin Pavel Mylnikov Elena Yakusheva Natalia Nikulina |
| author_sort | Sergey Seleznev |
| collection | DOAJ |
| description | (1) Background: This study was planned to assess the concentration of antihypertensive drugs (AHD) in the blood serum in patients with controlled and uncontrolled arterial hypertension (AH). (2) Methods: We assessed 46 patients with AH. Based on the results of 24 h blood pressure monitoring (ABPM), the patients were randomized into two groups. The first group consisted of the patients with controlled AH; the second group consisted of the patients with uncontrolled AH. Venous blood was taken in both groups of patients in the morning before and 2 h after taking drugs to assess the concentration of lisinopril, amlodipine, valsartan, and indapamide. (3) Results. The first group included 27 patients, and the second group 19 patients. In patients with uncontrolled AH, the median concentrations of lisinopril, indapamide, amlodipine, and valsartan before and after taking the drugs did not differ from patients who reached the target BP values. (<i>p</i> > 0.05). In some patients with uncontrolled and controlled (shown for the first time) AH the concentration of AHD was below the limit of quantitative determination. (4) Conclusions. The obtained results indicate that the pharmacokinetics of AHD, apparently, does not play a significant role in the development of ineffectiveness of the ongoing therapy for AH. Therapeutic drug monitoring can be used to test adherence to the treatment. |
| first_indexed | 2024-03-11T03:35:48Z |
| format | Article |
| id | doaj.art-b78e0a492b0b44e99a90915985ac5f1d |
| institution | Directory Open Access Journal |
| issn | 2075-4426 |
| language | English |
| last_indexed | 2024-03-11T03:35:48Z |
| publishDate | 2023-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Personalized Medicine |
| spelling | doaj.art-b78e0a492b0b44e99a90915985ac5f1d2023-11-18T02:04:31ZengMDPI AGJournal of Personalized Medicine2075-44262023-05-0113581510.3390/jpm13050815Therapeutic Drug Monitoring in Arterial HypertensionSergey Seleznev0Alexey Shchulkin1Pavel Mylnikov2Elena Yakusheva3Natalia Nikulina4Department of Hospital Therapy with a Course of Medical and Social Expertise, Ryazan State Medical University, Ryazan 390026, RussiaDepartment of Pharmacology, Ryazan State Medical University, Ryazan 390026, RussiaDepartment of Pharmacology, Ryazan State Medical University, Ryazan 390026, RussiaDepartment of Pharmacology, Ryazan State Medical University, Ryazan 390026, RussiaDepartment of Hospital Therapy with a Course of Medical and Social Expertise, Ryazan State Medical University, Ryazan 390026, Russia(1) Background: This study was planned to assess the concentration of antihypertensive drugs (AHD) in the blood serum in patients with controlled and uncontrolled arterial hypertension (AH). (2) Methods: We assessed 46 patients with AH. Based on the results of 24 h blood pressure monitoring (ABPM), the patients were randomized into two groups. The first group consisted of the patients with controlled AH; the second group consisted of the patients with uncontrolled AH. Venous blood was taken in both groups of patients in the morning before and 2 h after taking drugs to assess the concentration of lisinopril, amlodipine, valsartan, and indapamide. (3) Results. The first group included 27 patients, and the second group 19 patients. In patients with uncontrolled AH, the median concentrations of lisinopril, indapamide, amlodipine, and valsartan before and after taking the drugs did not differ from patients who reached the target BP values. (<i>p</i> > 0.05). In some patients with uncontrolled and controlled (shown for the first time) AH the concentration of AHD was below the limit of quantitative determination. (4) Conclusions. The obtained results indicate that the pharmacokinetics of AHD, apparently, does not play a significant role in the development of ineffectiveness of the ongoing therapy for AH. Therapeutic drug monitoring can be used to test adherence to the treatment.https://www.mdpi.com/2075-4426/13/5/815arterial hypertensionantihypertensive drugsHPLC MS/MS |
| spellingShingle | Sergey Seleznev Alexey Shchulkin Pavel Mylnikov Elena Yakusheva Natalia Nikulina Therapeutic Drug Monitoring in Arterial Hypertension Journal of Personalized Medicine arterial hypertension antihypertensive drugs HPLC MS/MS |
| title | Therapeutic Drug Monitoring in Arterial Hypertension |
| title_full | Therapeutic Drug Monitoring in Arterial Hypertension |
| title_fullStr | Therapeutic Drug Monitoring in Arterial Hypertension |
| title_full_unstemmed | Therapeutic Drug Monitoring in Arterial Hypertension |
| title_short | Therapeutic Drug Monitoring in Arterial Hypertension |
| title_sort | therapeutic drug monitoring in arterial hypertension |
| topic | arterial hypertension antihypertensive drugs HPLC MS/MS |
| url | https://www.mdpi.com/2075-4426/13/5/815 |
| work_keys_str_mv | AT sergeyseleznev therapeuticdrugmonitoringinarterialhypertension AT alexeyshchulkin therapeuticdrugmonitoringinarterialhypertension AT pavelmylnikov therapeuticdrugmonitoringinarterialhypertension AT elenayakusheva therapeuticdrugmonitoringinarterialhypertension AT natalianikulina therapeuticdrugmonitoringinarterialhypertension |